Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
CA 2296736 A1 · Owner: Beck, Alain · Inventors: Power, Ultan; Beck, Alain; Goestch, Liliane
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a polyclonal or monoclonal antibody directed against an epitope of the protein G of the syncytial respiratory virus corresponding to a sequence selected among one of the peptide sequences included respectively between the aminoacid residues 150-159 176-189, 194-207 and 155-176 of the entire sequence of the protein G of the syncytial respiratory virus A or B or of sequences having at least 98 % homology.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 17, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 17, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 17, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.